Cocoon Biotech
Cocoon Biotech: Developing a silk protein-based drug delivery platform for long-lasting joint pain relief.
Founded
2013Cocoon Biotech: Developing a silk protein-based drug delivery platform for long-lasting joint pain relief.
Cocoon Biotech, founded with a mission to leverage the unique properties of silk protein for medical applications, focuses on developing a biocompatible silk protein-based drug delivery platform. This innovative technology aims to provide long-lasting pain relief for joint conditions and potentially delay disease progression. The company’s core vision is to utilize the science of silk to build a healthier population and a sustainable planet, addressing the pervasive issue of petrochemical use in various industries.
Notable figures affiliated with Cocoon Biotech include experts in biotechnology and materials science, although specific names are not provided. The company has garnered attention for its pioneering approach to drug delivery, achieving significant milestones in preclinical studies. Cocoon Biotech's impact lies in its potential to revolutionize pain management and contribute to sustainable medical practices, positioning itself as a leader in the intersection of biotechnology and environmental sustainability.
Companies similar to Cocoon Biotech include Evolved By Nature, Silk Technologies, Extend Biosciences and Silk Therapeutics.
Cocoon Biotech was founded in 2013.
Cocoon Biotech's headquarters is located in Cambridge, MA, US.
Cocoon Biotech's most recent funding round was for $385.2k (USD) in December 2021.
As of Dec 13, 2021, Cocoon Biotech has disclosed funding of $5.7M (USD). Undisclosed round amounts are excluded.
Cocoon Biotech has 6 employees as of Feb 5, 2024.
Silk Therapeutics
